Click here for Kytril International
Tell A Friend Home   |     Site Map   |   Contact Us   |   Safety Information   |   Product Information  
 
Kytril granisetron HCI tablets, Oral Solutuion & IV
Cancer Patient
Ask Kytril
Just Type in your Question and click "Ask KYTRIL"
 Cancer Patient
 
 
 
Safety Information
The most frequently reported clinical adverse events occurring in >5% of patients receiving Kytril were headache, constipation, asthenia, diarrhea, abdominal pain*, dyspepsia*, pain, anemia, fever and elevated hepatic enzymes. The use of Kytril in patients following abdominal surgery or in patients with chemotherapy induced nausea and vomiting may mask progressive ileus and/or gastric distention.

*Associated with Kytril Tablets only.
Associated with Kytril Injection for postoperative nausea and vomiting only.


 
   
  Caring for a Cancer Patient
  Healthcare Professionals
Highlights
Beverly KirkhartMy Healing Companion
Introduction
What’s Your Personal Nfactor?
Use the Nfactor(TM) interactive
assessment tool
                    Nfactor
Patient Resource Center
 
 
   

Complete Product Information   I   Legal Statement   I   PRIVACY Statement

© 2009 Genentech USA, Inc. All rights reserved. This site is reserved for U.S. residents only.
  Genentech Logo